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Abstract
Background: Results of observational and experimental studies investigating the association between intake of long-chain
n-3 polyunsaturated fatty acids (PUFAs) and risk of atrial fibrillation (AF) have been inconsistent.
Methods: We studied the association of fish and the fish-derived n-3 PUFAs eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA) with the risk of incident AF in individuals aged 45–64 from the Atherosclerosis Risk in
Communities (ARIC) cohort (n=14,222, 27% African Americans). Intake of fish and of DHA and EPA were measured via food
frequency questionnaire. Plasma levels of DHA and EPA were measured in phospholipids in a subset of participants
(n=3,757). Incident AF was identified through the end of 2008 using ECGs, hospital discharge codes and death certificates.
Cox proportional hazards regression was used to estimate hazard ratios of AF by quartiles of n-3 PUFAs or by fish intake.
Results: During the average follow-up of 17.6 years, 1,604 AF events were identified. In multivariable analyses, total fish
intake and dietary DHA and EPA were not associated with AF risk. Higher intake of oily fish and canned tuna was associated
with a nonsignificant lower risk of AF (p for trend=0.09). Phospholipid levels of DHA+EPA were not related to incident AF.
However, DHA and EPA showed differential associations with AF risk when analyzed separately, with lower risk of AF in
those with higher levels of DHA but no association between EPA levels and AF risk.
Conclusions: In this racially diverse sample, dietary intake of fish and fish-derived n-3 fatty acids, as well as plasma
biomarkers of fish intake, were not associated with AF risk.
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Introduction
Consumption of fish and fish-derived n-3 PUFAs has been
shown to reduce the risk of cardiovascular disease [1,2],
particularly sudden cardiac death [3]. Similarly, consumption of
fish and n-3 PUFAs have been associated with more favorable
heart rate variability indices [4], and reduced risk of ventricular
arrhythmias [5] and all-cause mortality post myocardial infarction
(MI) [6].
Intake of fish and the fish-derived n-3 fatty acids DHA and EPA
may also reduce the risk of atrial fibrillation (AF), a common
cardiac arrhythmia associated with increased stroke and cardio-
vascular morbidity and mortality, which affects more than 2
million Americans [7]. However, studies investigating the associ-
ation between fish-derived n-3 PUFAs and incident AF have had
inconsistent results [8,9,10,11,12,13,14,15,16].
These observed inconsistencies may be due, in part, to
differences in dietary assessment methods, absolute quantities of
fish consumed, and dietary patterns associated with fish consump-
tion across different study populations. Specifically, measurement
error of fish intake, or any other dietary exposure, poses a
concerning issue since self-reported information is subject to recall
bias and biomarkers of fish intake (such as plasma levels of DHA
and EPA) only reflect exposure over a limited period of time and
are affected by multitude of metabolic processes [17]. Using a
combination of self-reported and objective measures (biomarkers)
of fish consumption in the same population might provide a more
accurate representation of the association with AF risk taking
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both self-reported measures of fish and dietary EPA and DHA
intake (derived from food frequency questionnaires (FFQ)) and
phospholipid measures of EPA and DHA to test the hypothesis
that fish and EPA and DHA are inversely associated with the risk
of incident AF in the Atherosclerosis Risk in Communities (ARIC)
Study, a population based cohort of middle aged American men
and women.
Methods
Study Population
The ARIC study has been described previously [18]. Briefly,
ARIC is a prospective study of cardiovascular disease including
15,792 men and women aged 45–64 years of age at baseline from
four US communities: Forsyth County, NC; Jackson, MS;
Minneapolis suburbs, MN; and Washington County, MD.
Baseline data were collected in 1987–89. Three additional exams
were done at 3-year intervals (1990–92, 1993–95, 1996–98).
Follow-up for cardiovascular outcomes is available through 2008.
The ARIC study has been approved by the Institutional Review
Boards (IRB) of all participating institutions, including the IRBs of
the University of Minnesota, Johns Hopkins University, University
of North Carolina, University of Mississippi Medical Center, and
Wake Forest University. All participants gave written informed
consent in each one of the study visits.
AF ascertainment
Incident cases of atrial fibrillation through December 31, 2008
were identified from three sources: hospital discharge codes
(International Classification of Diseases, Ninth Revision (ICD-9) codes
427.31 and 427.32), electrocardiograms (ECGs) performed during
follow-up exams, and death certificates (ICD-9 code 437.3 or
ICD-10 code I48) [19]. The positive predictive value of hospital
discharge codes for the diagnosis of incident AF, as determined
after review of hospital discharge summaries in a sample of ARIC
participants, was 89% [20].
Exposure assessment
Dietary intake of fish and the fish-derived PUFAs DHA and
EPA was ascertained using both self-report and biomarkers.
Participants reported their usual intake of different types of fish via
a food frequency questionnaire (FFQ). Additionally, blood plasma
levels of DHA and EPA were measured in a subset of participants.
Fish intake via FFQ: Participants’ usual dietary intake was
assessed by an interviewer-administered, 66-item FFQ. The FFQ
was a slightly modified version of the instrument developed by
Willett et al [21]. The FFQ was administered to all subjects at
baseline (1987–1989) and Exam 3 (1993–1995). For each food,
participants were asked to report the frequency of consumption
over the past year in 9 categories, ranging from ‘‘never or less than
once per month’’ to ‘‘.6 times per day.’’ Interviewers used food
models to help with portion size estimation. Fish and other seafood
intake was assessed through 4 questionnaire items: (1) 3–4 ounces
of canned tuna fish; (2) 3–5 ounces of dark meat fish such as
salmon, mackerel, swordfish, sardines, and bluefish; (3) 3–5 ounces
of other fish such as cod, perch, catfish, etc.; and (4) shrimp,
lobster, scallops as a main dish. FFQ responses were translated
into servings per week and subsequently categorized into four
categories: none, less than 1, 1–2, and more than two. The FFQ
did not collect information on fish preparation method.
DHA and EPA via FFQ: Nutrient values for each food were
obtained from the Harvard database [21] and daily intake of
nutrients was calculated by multiplying the nutrient content of
each food in the portion specified by the frequency of daily
consumption and then summing the results. This calculation
yielded consumption of EPA and DHA in grams/day. Fish-
derived n-3 fatty acid intake in visits 1 and 3 were significantly
correlated (r=0.47, p,0.0001, adjusted for age, race, and sex)
DHA and EPA in Plasma: Fatty acids levels were measured
in plasma samples from the Minnesota field center participants
(n=3,757) at baseline. Fatty acids were measured in plasma
cholesterol esters and phospholipids using gas chromatography,
yielding measures of plasma DHA and EPA as a percentage of
total fatty acids. The fatty acid profile of cholesterol esters reflects
medium-term (weeks) dietary intake of fatty acids while phospho-
lipids reflect intake over a slightly longer duration (weeks to
months) [22]. Only phospholipid measurements were used for the
present analysis.
Previous analyses in ARIC have shown that plasma DHA and
EPA measures correlate with dietary intake (as measured via a
food frequency questionnaire) with correlation coefficients ranging
from 0.20 (EPA) to 0.42 (DHA) [23].
Assessment of other variables: Cigarette smoking status
and amount, exercise amount, systolic blood pressure, LDL and
HDL cholesterols, alcohol intake, antihypertensive medication use,
diabetes status, anti-hyperglycemic medication use, weight, height,
and educational status were measured at baseline using standard-
ized methods [18]. Diabetes was defined as fasting blood glucose
$126 mg/dl, use of anti-hyperglycemic medications, or self-
reported history of physician-diagnosed diabetes. ECG-diagnosed
left ventricular hypertrophy (LVH) was considered present if the
Cornell voltage was .28 mm in men or .22 mm in women [24].
History of coronary heart disease (CHD) at baseline was defined as
one of the following: a self-reported history of a physician-
diagnosed myocardial infarction; evidence of previous myocardial
infarction in the baseline ECG; history of previous heart or arterial
surgery, including angioplasty or coronary bypass.
Participants with prevalent AF at baseline, who reported a race
other than white or black, and those with implausible calorie
intakes (,700 or .4500 for men, ,500 or .3500 for women)
were excluded. Participants with missing values for diabetes,
prevalent CHD, or LVH at baseline were imputed as having ‘‘no
disease.’’ Participants missing exposure values or other covariates
were excluded from analysis.
Statistical analysis
Cox proportional hazards regression models were used to
estimate hazard ratios (HRs) of incident AF by level of fish
consumption (0, ,1, 1–2, 2+ servings/week), quartiles of
DHA+EPA intake, and quartiles of phospholipid DHA+EPA.
Exposure status was a time-dependent covariate with baseline (visit
1) dietary data used as the exposure for the period between
baseline and visit 3, and the average intake of visits 1 and 3
afterwards. If visit 3 data were not available then visit 1 data were
used over the entire follow-up. The multivariable-adjusted models
included the following potential confounders as measured at
baseline: center, age, sex, race, BMI, total calories, alcohol intake
(grams/day), saturated fat intake (grams/day), fiber intake (grams/
day), vitamin C intake (mg/day), education level (less than high
school, high school, more than high school), cigarette smoking
status (current, former, never) and amount (pack years), LDL
cholesterol, HDL cholesterol, systolic blood pressure, use of
hypertensive medications, diabetes, LVH, and prevalent CHD.
Tests of linear trend were conducted by assigning the median
values for each category of exposure variable and modeling as a
continuous variable. To assess potential U-shaped associations,
tests of quadratic trend were done by using the linear trend values
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AF ascertainment affected our results, we repeated all analyses
including only AF events identified in study ECGs. We used the
residual method to adjust for total energy intake in analyses
considering dietary EPA and DHA as the main exposure [25].
Additional analyses were conducted combining the dietary data
with the biomarker data. Multivariable Cox proportional hazard
models were run using three different exposures: (1) subjects in the
highest tertiles of both FFQ-derived residual-adjusted intake and
phospholipid measures of DHA+EPA vs. those in lowest tertiles vs.
all others (3-level categorical variable); (2) Howe’s method [26]
with three categories (tertiles); and (3) Howe’s method with n
categories (n=3,743). Howe’s method ranks individuals by
categories of self-reported diet intake (DHA+EPA), then again
by biomarkers (DHA+EPA), then sums the two ranks [26]. Thus,
Howe’s method for three categories has a range of a combined
rank from 2 (lowest tertile for both dietary and phospholipid
exposures) to 6 (highest tertile for both dietary and phospholipid
exposures). Howe’s method for n categories ranks all subjects in
sequential order from lowest intake of DHA+EPA to highest.
Tests of the proportional hazards assumption were evaluated
using a time*exposure interaction term. Sex by exposure and race
by exposure interactions were also tested using a sex*exposure and
race*exposure interaction term. All p-values were 2-tailed. Data
were analyzed with SAS 9.2 for Windows (SAS Corp, Cary, NC).
Results
Baseline characteristics of the 14,222 eligible participants by
categories of fish intake (all ARIC field centers), and the 3,757
eligible participants by quartiles of DHA+EPA phospholipid levels
(Minnesota field center only) are shown in Table 1. Those who
consumed more fish tended to be older, female, and have a more
adverse cardiovascular risk profile. During the average follow-up
time of 17.6 years (249,775 person-years), 1,604 AF events were
identified. The proportional hazards assumption was not violated.
Risk of AF by Fish Intake Categories
Overall, fish intake was not associated with the incidence of AF
(table 2). The multivariable HR (95% CI) of AF in those
consuming .2 servings of fish/week was 1.00 (0.81–1.24)
compared to those not eating any fish (p for trend=0.15). Further
categorization of individuals with .2 serving of fish/week into
.2–3, .3–4, .4–5, and .5 servings/week did not show evidence
of an association (data not shown). Results were similar for canned
tuna (HR 0.85, 95% CI: 0.68–1.06), oily fish (HR 0.83, 95% CI:
0.58–1.21), other fish (HR 0.98, 95% CI: 0.76–1.27), and shellfish
(HR 0.81, 95% CI: 0.38–1.71), comparing .2 servings/week vs.
no intake. An analysis combining canned tuna and oily fish
showed a non-significant lower AF risk in those with .2 servings/
week vs no intake (HR 0.86, 95% CI 0.72–1.03, p for
trend=0.09). Results did not materially change when we included
only AF cases identified from study ECGs.
Risk of AF by DHA and EPA Intake
Intake of DHA+EPA was not associated with the incidence of
AF, with a HR (95% CI) of 0.92 (0.79–1.07) comparing extreme
quartiles (Table 3). Similar results were found when dietary DHA
and EPA were analyzed separately.
Risk of AF by Phospholipid Levels of DHA and EPA
Among the 3,757 eligible ARIC participants from the Minne-
apolis center with measurements of phospholipid fatty acids, 401
AF events occurred during an average follow-up time of 17.9 years
(67,081 person-years).
In multivariable analyses, the test for linear trend across
quartiles of phospholipid DHA+EPA for incident AF was not
statistically significant (table 4). When analyzed separately, DHA
showed a marginal U-shaped association (p for quadratic
term=0.10) with highest risk in the first quartile and in the last
quartile, lowest in the middle quartiles, and with point estimates
below 1.00 for intakes greater than the first quartile (table 4). In
contrast, EPA showed no association with the incidence of AF (Q4
vs. Q1, HR=1.12, 95% CI: 0.85–1.49).
Risk of AF by Combined Dietary and Biomarker
Categories
Among the 3,743 ARIC participants from the Minneapolis
center with measurements of phospholipid fatty acids and dietary
fatty acid intake, 400 AF events occurred during an average
follow-up of 17.9 years (66,834 person-years).
Participants with both dietary intake and phospholipid levels of
DHA+EPA in the highest tertiles did not have significantly
different risk of AF compared with those in the lowest tertiles
(table 5). Howe’s method with three categories yielded similar
results as well (table 5). Finally, Howe’s method with n categories
(n=3,743) did not provide any evidence of an association between
n-3 PUFA intake and AF risk. Comparing the estimated hazard
for the subject with the lowest intake of DHA+EPA (rank=1) with
the highest (rank=3,745) yielded a hazard ratio of 0.92 (95% CI:
0.74–1.14). Results were similar when exposure was restricted to
intake of oily fish and canned tune, and biomarker data on DHA
(data not shown).
Discussion
In this population-based study of middle-aged adults, we did not
observe strong associations of fish intake or dietary EPA and DHA
with risk of AF. However, our results suggest that the association
between fish-derived phospholipid n-3 PUFAs may differ for
individual fatty acids.
Overall, our results are consistent with those from the Women’s
Health Initiative [8], the Rotterdam Study [9], the Framingham
Heart Study [13], and the Danish Diet, Cancer, and Health Study
[10]: four large prospective cohorts that also failed to observe an
association between fish intake and AF risk. Only one previous
analysis in the Cardiovascular Health Study, involving a cohort of
Americans aged 65 years and older, found that higher consump-
tion of tuna or other non-fried fish was associated with a 30%
lower risk of AF (5+ servings/week vs. ,1 serving/month,
RR=0.70, 95% CI: 0.53–0.93) [12]. Notably, the Cardiovascular
Health Study had a large proportion of subjects with high fish
consumption (19% ate 5+ servings/week of tuna or other fish vs.
8.3% in ARIC), suggesting that a higher intake than that observed
in the present study might be necessary to illicit any effect on AF
risk as has been observed for other cardiovascular outcomes
[12,27]. Our finding that higher intake of oily fish and canned
tuna in the ARIC cohort was associated with a lower, though non-
significant, risk of AF is consistent with the results from the
Cardiovascular Health Study.
Our data suggested that phospholipid EPA and DHA may be
differentially associated with AF risk, with no association between
EPA levels and AF risk and a U- or L-shaped association between
DHA and AF risk. Two previous studies have explored the
associations between blood levels of DHA and EPA—as biomark-
ers of fish intake—and AF risk. A Finnish prospective study found
an inverse association between blood serum levels of total fish-
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extreme quartiles) and DHA (RR=0.51, 95% CI: 0.32–0.82,
comparing extreme quartiles) with incident AF, but no association
was seen for other n-3 PUFAs (EPA, docosapentaenoic acid) [14].
Very similar results were found in the Cardiovascular Health
Study [16]. ARIC results are somewhat consistent with these two
studies, though fish intake in both studies was higher than that
observed in the ARIC cohort. In ARIC subjects, the highest
DHA+EPA quartile contained values .3.83% whereas Finland’s
Kuopio Ischemic Heart Disease Risk Factor Study had values
,3.61% in the lowest quartile and .5.33% in the highest [14],
and average total n-3 PUFA concentration in the Cardiovascular
Health Study was 4.5%. In addition, a recent small case-control
study in Italy found that levels of n-3 PUFA in erythrocyte
membranes were higher in cases of idiopathic AF than in controls
(31.4% vs. 23.5%, p,0.001) [15], but this later study did not
adjust for potential confounders and, therefore, its interpretation is
problematic.
Measurement error may be partly responsible for the inconsis-
tent results across studies. Phospholipid measurement of n-3 fatty
acids, less subject to self-report measurement error, could better
elucidate the relationship between n-3 fatty acids and AF.
However, our results combining phospholipid and dietary data
were similarly null.
Other reasons for why certain subgroups show an inverse
association between n-3 PUFAs and AF include dose and relevant
exposure period. Some trials [28,29,30] (but not all [31,32]) have
shown that fish oil supplementation pre- and post-coronary artery
bypass graft (CABG) or open heart surgery reduces the risk of
AF—especially in the immediate aftermath [29]. These studies
Table 1. Baseline characteristics of ARIC participants (n=14,222), 1987–1989.
Serving of fish/week
0 ,11 – 2 .2
Number of Subjects (%) 612 (4.3) 2641 (18.6) 5686 (40) 5283 (37.1)
Age 55 (6.0) 54.2 (5.8) 54.2 (5.7) 54 (5.7)
Sex (men) 48.0 51.7 54.5 58.9
Race (White) 88.9 89.6 76.8 64.5
BMI 27.2 (5.4) 27.1 (4.8) 27.5 (5.3) 28.2 (5.5)
Hypertension 28.6 28.9 34.2 37.2
Current smoking 29.7 25.2 26.7 24.5
Diabetes 10.8 9.4 11.2 12.9
ECG defined LVH 1.5 1.8 2 2.3
CHD 5.4 3.9 4.6 5.2
Alcohol intake (g/day) 5.6 (14.1) 6.2 (13.8) 6.4 (13.6) 5.8 (13.3)
Total energy intake (Kcal/day) 1504.4 (605.9) 1478.9 (572.4) 1561.8 (564.2) 1747.3 (611.0)
Fish-derived n-3 fatty acids (g/day) 0.02 (0.02) 0.08 (0.05) 0.19 (0.09) 0.48 (0.34)
Fiber (g/day) 15.6 (8.7) 14.9 (7.2) 16.4 (7.3) 19.7 (9)
Vitamin C (mg/day) 104.5 (79.9) 99.6 (73.9) 116.4 (77.7) 142.8 (91.6)
Saturated Fat (g/day) 21.8 (11) 21.3 (10.5) 21.9 (10.5) 22.4 (10.8)
Quartile of DHA+EPA (Minnesota participants only, n=3,817)
Q1 Q2 Q3 Q4
Range (% total fatty acid) 0.73–2.7 2.71–3.2 3.21–3.82 3.83–12.19
Number of Subjects (%) 410 (21) 483 (24.7) 550 (28.1) 511 (26.2)
Age 53.5 (5.6) 53.9 (5.7) 53.9 (5.6) 54.4 (5.6)
Sex (men) 55.68 48.51 41.8 46.15
BMI 26.6 (4.4) 27.5 (4.9) 27.3 (4.7) 26.7 (4.3)
Hypertension 24.86 24.31 27.09 25.29
Current smoking 34.38 21.86 18.84 14.12
Diabetes 6.16 8 7.3 7.38
ECG defined LVH 1.19 0.96 0.74 0.95
CHD 3.89 4.05 4.76 4.95
Alcohol intake (g/day) 9.8 (15.7) 8.7 (14.7) 7.6 (14.7) 7.4 (12)
Fiber (g/day) 15.5 (7.4) 15.8 (7.3) 16.1 (7.1) 17.4 (7.4)
Vitamin C (mg/day) 103.7 (72.2) 109.5 (71.4) 109.6 (62) 119.4 (68.9)
Saturated Fat (g/day) 24.9 (11.2) 23.8 (11.3) 22.1 (9.7) 20.7 (9.8)
Values are % for categorical variables and mean (SD) for continuous variables. BMI: Body mass index. CHD: Coronary heart disease. DHA: Docosahexaenoic acid. ECG:
Electrocardiogram. EPA: Eicosapentanoic acid.
doi:10.1371/journal.pone.0036686.t001
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done in subjects at high risk for AF. Similarly, trials investigating
n-3 PUFA supplementation once AF has been established have
also shown mixed results [33,34]. This may suggest that the
administration of high-dose n-3 PUFA supplementation (as
opposed to usual intake) in high-risk subjects might have a
preventive effect, though further research is required.
In spite of the lack of strong and consistent epidemiologic
evidence for an inverse association of n-3 PUFAs with AF,
several mechanisms suggest that such an effect might exist. First,
fish-derived n-3 PUFAs may prevent AF by preventing the
structural heart damage that is a precursor to AF. Previous
research has shown that fish-derived n-3 PUFAs protect against
CHD [1,2], a risk factor for AF [35]. Second, n-3 PUFAs may
inhibit the inflammatory triggers that occasionally initiate the
ectopic activity in AF [36,37]. Finally, even once that electrical
activity has been stimulated, fish-derived n-3 PUFAs may
inhibit the fast, voltage-dependent sodium current and the L-type
calcium currents [38,39] that would allow the arrhythmia to be
sustained.
Our study is not without limitations. Data were not available on
fish preparation technique. Analysis in the Cardiovascular Health
Study have shown that fish preparation method differentially
effects the association between fish-derived n-3 PUFAs and CHD,
with only intake of tuna and other baked or broiled fish associated
with cardiovascular benefits, with no or deleterious associations for
fried fish or fish sandwiches [2,40]. Lack of information on fish
preparation method in ARIC could be responsible for our failure
to show an association between fish intake and AF risk. The
relatively low correlation between dietary and plasma EPA and
DHA in the ARIC sample further suggests that measurement
error is an important limitation.[23] Additionally, the range of fish
Table 2. Hazard ratios (95% confidence intervals) of atrial fibrillation by fish intake categories, ARIC, 1987–2008.
Total Fish (servings/week) 0 ,11 – 2 .2 P for trend
AF cases 66 309 679 550
Person-years 10,108 47,073 98,733 93,861
Model 1 [HR (95% CI)] 1 (ref.) 1.04 (0.84, 1.29) 1.12 (0.92, 1.35) 0.99 (0.80, 1.21) 0.37
Model 2 [HR (95% CI)] 1 (ref.) 1.13 (0.91, 1.40) 1.16 (0.95, 1.40) 1.00 (0.81, 1.24) 0.15
Canned Tuna (servings/week) 0 ,11 – 2 .2
AF cases 394 792 326 92
Person-years 53,825 125,261 52,237 18,453
Model 1 [HR (95% CI)] 1 (ref.) 0.97 (0.86, 1.10) 1.01 (0.87, 1.17) 0.94 (0.76, 1.17) 0.77
Model 2 [HR (95% CI)] 1 (ref.) 0.98 (0.87, 1.11) 0.97 (0.84, 1.13) 0.85 (0.68, 1.06) 0.17
Oily Fish (servings/week) 0 ,11 – 2 .2
AF cases 664 768 148 24
Person-years 108,509 114,245 22,226 4,795
Model 1 [HR (95% CI)] 1 (ref.) 1.04 (0.93, 1.15) 0.99 (0.83, 1.18) 0.89 (0.61, 1.28) 0.67
Model 2 [HR (95% CI)] 1 (ref.) 1.03 (0.92, 1.14) 0.97 (0.81, 1.16) 0.83 (0.58, 1.21) 0.44
Canned Tuna + Oily Fish (servings/
week) 0 ,11 – 2 .2
AF cases 425 429 572 178
Person-years 60,541 66,681 89,598 32,955
Model 1 [HR (95% CI)] 1 (ref.) 0.96 (0.84–1.09) 0.97 (0.85–1.10) 0.90 (0.76–1.07) 0.27
Model 2 [HR (95% CI)] 1 (ref.) 0.98 (0.85–1.12) 0.95 (0.83–1.08) 0.86 (0.72–1.03) 0.09
Other Fish (servings/week) 0 ,11 – 2 .2
AF cases 377 842 321 64
Person-years 56,467 128,878 52,975 11,456
Model 1 [HR (95% CI)] 1 (ref.) 1.03 (0.91, 1.17) 0.96 (0.82, 1.12) 0.97 (0.76, 1.26) 0.66
Model 2 [HR (95% CI)] 1 (ref.) 1.08 (0.96, 1.23) 0.98 (0.84, 1.14) 0.98 (0.76, 1.27) 0.68
Shellfish (servings/week) 0 ,11 – 2 .2
AF cases 846 673 77 8
Person-years 129,037 107,438 11,716 1,584
Model 1 [HR (95% CI)] 1 (ref.) 1.01 (0.91, 1.12) 1.19 (0.96, 1.49) 0.87 (0.41, 1.83) 0.51
Model 2 [HR (95% CI)] 1 (ref.) 1.04 (0.93, 1.15) 1.16 (0.92, 1.46) 0.81 (0.38, 1.71) 0.54
CI: Confidence interval. HR: Hazard ratio. Model 1: adjusted for age, sex, and race; Model 2: adjusted for center, age, race, sex, energy intake, body mass index, education,
exercise levels, smoking status and amount, alcohol intake, LDL cholesterol, HDL cholesterol, use of cholesterol lowering medications, systolic blood pressure, use of
antihypertensive medications, diabetes, coronary heart disease, and ECG-defined left ventricular hypertrophy.
doi:10.1371/journal.pone.0036686.t002
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inhibited our ability to find an association. Also, diet was measured
at baseline and at a follow-up visit, but changes in fish
consumption after visit 3 could not be assessed, potentially
creating additional nondifferential measurement error of the
exposure. Finally, AF ascertainment was mostly based on hospital
discharge codes, which limited the ability to identify paroxysmal
AF and AF managed in outpatient settings. Our previous
validation study, however, suggests that hospital discharges are
an adequate method for AF ascertainment in epidemiologic
studies [20].
In summary, our results suggest that, in a sample with low-
moderate average fish intake, usual fish and n-3 PUFAs intake is
not strongly associated with AF risk. We have observed, consistent
Table 3. Hazard ratios (95% confidence interval) of atrial fibrillation by categories of DHA+EPA intake, ARIC, 1987–2008.
Dietary DHA+EPA (Quartiles)Q1 Q2 Q3 Q4 P for trend
AF cases 402 427 409 366
Person-years 61,943 62,339 62,270 63,223
Model 1 [HR (95% CI)] 1 (ref.) 1.03 (0.90, 1.19) 1.06 (0.91, 1.23) 0.95 (0.82, 1.10) 0.42
Model 2 [HR (95% CI)] 1 (ref.) 1.04 (0.90, 1.20) 1.06 (0.91, 1.23) 0.92 (0.79, 1.07) 0.21
Dietary DHA (Quartiles) Q1 Q2 Q3 Q4
AF cases 404 428 410 362
Person-years 61,750 62,584 62,134 63,307
Model 1 [HR (95% CI)] 1 (ref.) 1.06 (0.92, 1.22) 1.05 (0.90, 1.22) 0.97 (0.83, 1.12) 0.48
Model 2 [HR (95% CI)] 1 (ref.) 1.06 (0.92, 1.23) 1.05 (0.90, 1.22) 0.93 (0.80, 1.09) 0.21
Dietary EPA (Quartiles) Q1 Q2 Q3 Q4
AF cases 412 418 392 382
Person-years 61,962 62,298 62,701 62,815
Model 1 [HR (95% CI)] 1 (ref.) 1.07 (0.93, 1.23) 1.00 (0.86, 1.16) 0.96 (0.83, 1.12) 0.41
Model 2 [HR (95% CI)] 1 (ref.) 1.05 (0.91, 1.22) 1.00 (0.86, 1.16) 0.93 (0.80, 1.08) 0.22
Dietary DHA and EPA adjusted for energy using the residual method. CI: Confidence interval. HR: Hazard ratio. Model 1: adjusted for age, sex, and race; Model 2:
adjusted for center, age, race, sex, energy intake, BMI, education, exercise levels, smoking status and amount, alcohol intake, HDL-C, LDL-C, use of cholesterol lowering
medications, systolic blood pressure, use of antihypertensive medications, diabetes, coronary heart disease, and ECG-defined left ventricular hypertrophy.
doi:10.1371/journal.pone.0036686.t003
Table 4. Hazard ratios (95% confidence interval) of atrial fibrillation by quartiles of Phospholipid DHA and EPA, ARIC Minnesota
field center, 1987–2008.
Phospholipid DHA+EPA
(Quartiles) Q1 Q2 Q3 Q4 P for trend
AF cases 112 95 93 101
Person-years 16,114 16,994 16,829 17,144
Model 1 [HR (95% CI)] 1 (ref.) 0.77 (0.58, 1.01) 0.80 (0.61, 1.05) 0.79 (0.60, 1.03) 0.18
Model 2 [HR (95% CI)] 1 (ref.) 0.80 (0.6, 1.06) 0.81 (0.61, 1.08) 0.87 (0.66, 1.15) 0.54
Phospholipid DHA From Plasma
(Quartiles) Q1 Q2 Q3 Q4
AF cases 117 86 99 99
Person-years 16,118 16,961 16,849 17,153
Model 1 [HR (95% CI)] 1 (ref.) 0.68 (0.52, 0.90) 0.78 (0.60, 1.02) 0.74 (0.57, 0.97) 0.10
Model 2 [HR (95% CI)] 1 (ref.) 0.71 (0.54, 0.95) 0.82 (0.62, 1.08) 0.84 (0.63, 1.11) 0.47
Phospholipid EPA (Quartiles) Q1 Q2 Q3 Q4
AF cases 99 86 106 110
Person-years 17,325 15,505 17,217 17,034
Model 1 [HR (95% CI)] 1 (ref.) 1.00 (0.75, 1.34) 1.11 (0.84, 1.46) 1.11 (0.85, 1.46) 0.38
Model 2 [HR (95% CI)] 1 (ref.) 0.98 (0.73, 1.31) 1.04 (0.78, 1.37) 1.12 (0.85, 1.49) 0.33
CI: Confidence interval. HR: Hazard ratio. Model 1: adjusted for age and sex; Model 2: adjusted for age, sex, BMI, education, exercise levels, smoking status and amount,
alcohol intake, HDL-C, LDL-C, use of cholesterol lowering medications, systolic blood pressure, use of antihypertensive medications, diabetes, coronary heart disease,
and ECG-defined left ventricular hypertrophy.
doi:10.1371/journal.pone.0036686.t004
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have dissimilar associations with the risk of AF.
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